Rothen, Dominik Alexander

Up a level
Export as [feed] RSS
Group by: Date | Item Type | Refereed | No Grouping
Jump to: Yes

Yes

Sobczak, Jan M; Barkovska, Irena; Balke, Ina; Rothen, Dominik A; Mohsen, Mona O; Skrastina, Dace; Ogrina, Anete; Martina, Byron; Jansons, Juris; Bogans, Janis; Vogel, Monique; Bachmann, Martin F; Zeltins, Andris (2024). Identifying Key Drivers of Efficient B Cell Responses: On the Role of T Help, Antigen-Organization, and Toll-like Receptor Stimulation for Generating a Neutralizing Anti-Dengue Virus Response. Vaccines, 12(6) MDPI 10.3390/vaccines12060661

Josi, Romano; Ogrina, Anete; Rothen, Dominik; Balke, Ina; Solé Casaramona, Arnau; de Brot, Simone; Mohsen, Mona O. (2024). Intranodal Injection of Immune Activator Demonstrates Antitumor Efficacy in an Adjuvant Approach. Vaccines, 12(4) MDPI 10.3390/vaccines12040355

Rothen, Dominik A; Krenger, Pascal S; Nonic, Aleksandra; Balke, Ina; Vogt, Anne-Cathrine S; Chang, Xinyue; Manenti, Alessandro; Vedovi, Fabio; Resevica, Gunta; Walton, Senta M; Zeltins, Andris; Montomoli, Emanuele; Vogel, Monique; Bachmann, Martin F; Mohsen, Mona O (2022). Intranasal administration of a VLP-based vaccine induces neutralizing antibodies against SARS-CoV-2 and variants of concern. Allergy, 77(8), pp. 2446-2458. Wiley 10.1111/all.15311

Mohsen, Mona O.; Balke, Ina; Zinkhan, Simon; Zeltina, Villija; Liu, Xuelan; Chang, Xinyue; Krenger, Pascal S.; Plattner, Kevin; Gharailoo, Zahra; Vogt, Anne-Cathrine S.; Augusto, Gilles; Zwicker, Marianne; Roongta, Salony; Rothen, Dominik A.; Josi, Romano; J. Da Costa, Joana; Sobczak, Jan M.; Nonic, Aleksandra; Brand, Lee-Anne; Nuss, Katja; ... (2022). A scalable and highly immunogenic virus-like particle-based vaccine against SARS-CoV-2. Allergy, 77(1), pp. 243-257. Wiley 10.1111/all.15080

Mohsen, Mona O.; Rothen, Dominik; Balke, Ina; Martina, Byron; Zeltina, Vilija; Inchakalody, Varghese; Gharailoo, Zahra; Nasrallah, Gheyath; Dermime, Said; Tars, Kaspars; Vogel, Monique; Zeltins, Andris; Bachmann, Martin F. (2021). Neutralization of MERS coronavirus through a scalable nanoparticle vaccine. NPJ vaccines, 6(1), p. 107. Springer Nature 10.1038/s41541-021-00365-w

Liu, Xuelan; Chang, Xinyue; Rothen, Dominik; Derveni, Mariliza; Krenger, Pascal; Roongta, Salony; Wright, Edward; Vogel, Monique; Tars, Kaspars; Mohsen, Mona O.; Bachmann, Martin F. (2021). AP205 VLPs Based on Dimerized Capsid Proteins Accommodate RBM Domain of SARS-CoV-2 and Serve as an Attractive Vaccine Candidate. Vaccines, 9(4) MDPI 10.3390/vaccines9040403

Provide Feedback